Edition:
United States

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

7.07USD
4:00pm EDT
Change (% chg)

$-0.08 (-1.12%)
Prev Close
$7.15
Open
$7.13
Day's High
$7.13
Day's Low
$7.07
Volume
2
Avg. Vol
4,271
52-wk High
$13.50
52-wk Low
$6.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.028
FY 2017 Dec '17
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
FY 2016 Dec '16 0.00 -0.021
Sep '16 0.00 -0.071
Jun '16 0.00 -0.039
Mar '16 0.00 -0.049
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 235.76 33.88
P/E High - Last 5 Yrs. -- 288.75 47.66
P/E Low - Last 5 Yrs. -- 99.96 25.18
Beta 2.09 0.73 0.78
Price to Sales (TTM) -- 260.48 8.30
Price to Book (MRQ) 7.74 23.31 4.32
Price to Tangible Book (MRQ) 6.82 30.41 5.99
Price to Cash Flow (TTM) -- 138.67 22.70
% Owned Institutions -- 11.74 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.69
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.20 -6.64
Payout Ratio(TTM) -- 41.81 40.53

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 24.25 5.00
Sales (TTM) vs TTM 1 Yr. Ago -- 136.30 12.65
Sales - 5 Yr. Growth Rate -- 30.91 7.92
EPS (MRQ) vs Qtr. 1 Yr. Ago 79.39 -78.19 40.28
EPS (TTM) vs TTM 1 Yr. Ago 46.44 -- --
EPS - 5 Yr. Growth Rate -- 48.46 8.01
Capital Spending - 5 Yr. Growth Rate 80.20 36.01 7.43

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.55
Current Ratio (MRQ) 11.01 6.32 3.64
LT Debt to Equity (MRQ) 0.00 22.16 12.89
Total Debt to Equity (MRQ) 0.00 26.56 17.35
Interest Coverage (TTM) -2.86 -139.50 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.80 54.88
Gross Margin - 5 Yr. Avg. -- 55.31 52.82
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -166.28 15.78
Operating Margin (TTM) -- -923.67 -0.49
Operating Margin - 5 Yr. Avg. -- -179.82 11.04
Pre-Tax Margin (TTM) -- -813.20 1.49
Pre-Tax Margin - 5 Yr. Avg. -- -183.43 11.21
Net Profit Margin (TTM) -- -806.44 -1.80
Net Profit Margin - 5 Yr. Avg. -- -182.19 7.56
Effective Tax Rate (TTM) -- 15.36 29.88
Effective Tax Rate - 5 Yr. Avg. -- 19.24 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,567,119 743,658,643
Net Income/Employee (TTM) -- -160,062 86,499,502
Receivable Turnover (TTM) -- 18.13 6.06
Inventory Turnover (TTM) -- 2.87 3.64
Asset Turnover (TTM) 0.00 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -58.41 -3.67 10.40
Return on Assets - 5 Yr. Avg. -77.20 -0.80 11.13
Return on Investment (TTM) -64.02 -5.45 13.21
Return on Investment - 5 Yr. Avg. -87.94 2.04 14.44
Return on Equity (TTM) -86.58 -6.94 15.18
Return on Equity - 5 Yr. Avg. -96.80 -3.02 15.79
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -49.97 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.